Neogen Corporation (NEOG): Price and Financial Metrics

NEOG POWR Grades

• Value is the dimension where NEOG ranks best; there it ranks ahead of 37.35% of US stocks.
• NEOG's strongest trending metric is Quality; it's been moving down over the last 177 days.
• NEOG's current lowest rank is in the Sentiment metric (where it is better than 7.4% of US stocks).

NEOG Stock Summary

• NEOGEN CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 17.44% of US listed stocks.
• NEOG's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 329.39 -- higher than 91.08% of US-listed equities with positive expected earnings growth.
• NEOG's price/sales ratio is 6.24; that's higher than the P/S ratio of 83.07% of US stocks.
• Stocks that are quantitatively similar to NEOG, based on their financial statements, market capitalization, and price volatility, are CYRX, CIR, NTIC, ZUMZ, and CENT.
• Visit NEOG's SEC page to see the company's official filings. To visit the company's web site, go to www.neogen.com.

NEOG Valuation Summary

• In comparison to the median Healthcare stock, NEOG's price/sales ratio is 31.91% higher, now standing at 6.2.
• Over the past 243 months, NEOG's EV/EBIT ratio has gone up 242.4.

Below are key valuation metrics over time for NEOG.

NEOG Growth Metrics

Its 2 year cash and equivalents growth rate is now at -15.55%.
• Its year over year price growth rate is now at -29.08%.
• Its 2 year net cashflow from operations growth rate is now at -14.19%.

Over the past 52 months, NEOG's revenue has gone up $224,097,000.

The table below shows NEOG's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	630.719	-5.888	-16.23
2022-09-30	531.203	30.685	36.439
2022-06-30	527.159	68.038	48.307
2022-03-31	514.491	69.617	49.108
2021-12-31	502.956	74.622	57.042
2021-09-30	487.439	79.165	62.099

NEOG's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NEOG has a Quality Grade of C, ranking ahead of 68.43% of graded US stocks.
• NEOG's asset turnover comes in at 0.545 -- ranking 74th of 680 Pharmaceutical Products stocks.
• UTHR, HSKA, and VNDA are the stocks whose asset turnover ratios are most correlated with NEOG.

The table below shows NEOG's key quality metrics over time.